Monday, 27 December 2010

Edetic Acid




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000060-00-4

Chemical Formula

C10-H16-N2-O8

Molecular Weight

292

Therapeutic Categories

Pharmaceutic aid

Antidote: Chelating agent

Chemical Name

Ethylendiamino-N,N,N',N'-tetra-acetic acid (WHO)

Foreign Names

  • Acidum edeticum (Latin)
  • Edetinsäure (German)
  • Acide édétique (French)
  • Ácido edético (Spanish)

Generic Names

  • Acide édétique (OS: DCF)
  • Acido edetico (OS: DCIT)
  • Edetic Acid (OS: BAN)
  • (Ethylene dinitrilo) tetraacetic acid (IS)
  • Ae DTE (IS)
  • Diaminoethanetetraacetic acid (IS)
  • EDTA (IS)
  • Ethylendiamintetraessigsäure (IS)
  • Ethylendiamintetraethansäure (IS)
  • Ethylendinitrilotetraessigsäure (IS)
  • Ethylene diamine tetraacetic acid (IS)
  • Tetrine acid (IS)
  • Versene acid (IS)
  • Acidum edeticum (PH: Ph. Eur. 6)
  • Edetic Acid (PH: BP 2010, NF 27, Ph. Eur. 6)
  • Edetinsäure (PH: Ph. Eur. 6)
  • Edétique (acide) (PH: Ph. Eur. 6)
  • Edetate Calcium Disodium (OS: USAN)
  • Sodium (calcium édétate de) (OS: DCF)
  • Sodium Calcium Edetate (OS: BAN)
  • Edathamil calcium-disodium (IS)
  • EDTA Calcium (IS)
  • Edetate Calcium Disodium (PH: USP 32)
  • Natrii calcii edetas (PH: Ph. Int. 4, Ph. Eur. 6)
  • Natriumcalciumedetat (PH: Ph. Eur. 6)
  • Sodium (calcium édétate de) (PH: Ph. Eur. 6)
  • Sodium Calcium Edetate (PH: BP 2010, Ph. Eur. 6)
  • Dicobalt Edetate (OS: BAN)
  • Cobalt tetracemate (IS)
  • Edetinsäure, Dikobalt-Salz (IS)
  • Disodium Edetate (OS: BAN, JAN)
  • Sodium (édétate de) (OS: DCF)
  • Disodium Ethylenediaminetetraacetate (IS)
  • Disodium Tetrine (IS)
  • Edetinsäure, Dinatriumsalz-2-Wasser (IS)
  • Tetracemate disodium (IS)
  • Dinatrii edetas (PH: Ph. Int. 4, Ph. Eur. 6)
  • Disodium Edetate (PH: BP 2007, Ph. Eur. 6, Ph. Int. 4, JP XIV)
  • Disodium Edetate Hydrate (PH: JP XV)
  • Edétate disodique (PH: Ph. Eur. 6)
  • Edetate Disodium (PH: USP 32)
  • Natriumedetat (PH: Ph. Eur. 6)
  • Edetate Trisodium (OS: USAN)
  • Edetinsäure, Trinatrium-Salz (IS)
  • Trisodium EDTA (IS)
  • Trisodium Edetate Injection (PH: BP 1999)

Brand Names

  • EDTA Llorens
    Llorens, Spain


  • Bleian S
    Nisshin Seiyaku - Yamagata, Japan


  • Bleian
    Nisshin Seiyaku - Yamagata, Japan


  • Calcium Disodium Versenate
    Douglas, New Zealand; Graceway, United States; iNova Pharmaceuticals, Australia


  • Calcium Edétate de Sodium Serb
    SERB, France


  • Calsenate (veterinary use)
    Parnell Laboratories, Australia


  • Edetamin
    Terapia, Romania


  • Ledclair
    Durbin, United Kingdom; Sinclair, Ireland


  • Sodio Calcio Edetato
    Monico, Italy; Salf, Italy


  • Versenato Calcico Disodico
    3M, Chile


  • Dicobalt Edetate
    3M, Australia; Cambridge Laboratories, United Kingdom


  • Kelocyanor
    IFET, Greece


  • Kélocyanor
    Cahill May Roberts, Ireland; SERB, France


  • Premier Dicobalt Edetate
    Adcock Ingram Pharmaceuticals, South Africa


  • Chelatran
    SERB, France


  • Edetate Disodium
    Centre for Advanced Medicine, New Zealand


  • Morhonine For Dental Use (Edetic Acid and Cetrimide)
    Showa Yakuhin Kako, Japan


  • N.A.C. (Edetic Acid and Acetylcysteine (veterinary use))
    Laboratoire TVM, France


  • Sodio Edetato
    Galenica, Italy; Monico, Italy; Salf, Italy


  • Limclair
    Sinclair, Ireland

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Algozone




Algozone may be available in the countries listed below.


Ingredient matches for Algozone



Metamizole

Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Algozone in the following countries:


  • Bulgaria

  • Hungary

  • Romania

International Drug Name Search

Sunday, 26 December 2010

Breva




Breva may be available in the countries listed below.


Ingredient matches for Breva



Ipratropium

Ipratropium Bromide is reported as an ingredient of Breva in the following countries:


  • Italy

Salbutamol

Salbutamol is reported as an ingredient of Breva in the following countries:


  • Italy

International Drug Name Search

Merck-Fluconazole




Merck-Fluconazole may be available in the countries listed below.


Ingredient matches for Merck-Fluconazole



Fluconazole

Fluconazole is reported as an ingredient of Merck-Fluconazole in the following countries:


  • South Africa

International Drug Name Search

Friday, 24 December 2010

Folipiron




Folipiron may be available in the countries listed below.


Ingredient matches for Folipiron



Flopropione

Flopropione is reported as an ingredient of Folipiron in the following countries:


  • Japan

International Drug Name Search

Busulfex


Pronunciation: bue-SUL-fan
Generic Name: Busulfan
Brand Name: Busulfex

Busulfex causes severe bone marrow depression which may lead to severe anemia (eg, aplastic anemia). This may reduce the ability of the body to fight infection or cancer. It may also reduce the ability of your blood to clot properly, which could result in severe bleeding. Your doctor will perform lab tests, including complete blood cell counts, to monitor your progress and to check for side effects. Be sure to keep all doctor and lab appointments.





Busulfex is used for:

Preparing the body for a hematopoietic stem cell transplant in combination with another medicine (cyclophosphamide) in patients with chronic myelogenous leukemia.


Busulfex is an alkylating agent. It works by slowing down reproduction and growth of certain white blood cells.


Do NOT use Busulfex if:


  • you are allergic to any ingredient in Busulfex

  • you are also taking metronidazole

Contact your doctor or health care provider right away if any of these apply to you.



Before using Busulfex:


Some medical conditions may interact with Busulfex. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have bone marrow depression, blood problems (eg, porphyria, thalassemia), a head injury, or a history of seizures (eg, epilepsy)

  • if you have undergone chemotherapy or radiation or have previously or are currently taking any other medicines for cancer

Some MEDICINES MAY INTERACT with Busulfex. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Acetaminophen, itraconazole, or metronidazole because the risk of toxic side effects of Busulfex may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Busulfex may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Busulfex:


Use Busulfex as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Busulfex is usually given as an injection at your doctor's office, hospital, or clinic. If you will be using Busulfex at home, a health care provider will teach you how to use it. Be sure you understand how to use Busulfex. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.

  • Do not use Busulfex if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.

  • Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.

  • If you miss a dose of Busulfex, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Busulfex.



Important safety information:


  • Busulfex may cause dizziness or drowsiness. These effects may be worse if you take it with alcohol or certain medicines. Use Busulfex with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • If Busulfex accidentally spills on your skin, wash it off immediately with soap and water.

  • If nausea, vomiting, or loss of appetite occurs, do not stop using your medicine. Ask your doctor, nurse, or pharmacist for ways to lessen these effects.

  • Busulfex may lower the ability of your body to fight infection. Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills. Do not touch your eyes or the inside of your nose unless you have thoroughly washed your hands first.

  • Busulfex may reduce the number of clot-forming cells (platelets) in your blood. Avoid activities that may cause bruising or injury. Tell your doctor if you have unusual bruising or bleeding. Tell your doctor if you have dark, tarry, or bloody stools.

  • Do not receive a live vaccine (eg, measles, mumps) while you are taking Busulfex. Talk with your doctor before you receive any vaccine.

  • Tell your doctor or dentist that you take Busulfex before you receive any medical or dental care, emergency care, or surgery.

  • Busulfex increases the risk of a second cancer in future years. It may also cause a rare but serious lung problem (bronchopulmonary dysplasia with pulmonary fibrosis) within months to years after treatment with Busulfex. Talk with your doctor if you have questions about your risk for these problems.

  • Busulfex may cause infertility. Talk with your doctor if you have any questions or concerns.

  • Busulfex may raise your blood sugar. High blood sugar may make you feel confused, drowsy, or thirsty. It can also make you flush, breathe faster, or have a fruit-like breath odor. If these symptoms occur, tell your doctor right away.

  • Lab tests, including liver function tests, blood sugar levels, blood electrolytes, complete blood cell counts, and bone marrow tests, may be performed while you use Busulfex. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Busulfex should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Busulfex has been shown to cause harm to the fetus. Do not become pregnant while you are using it. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Busulfex while you are pregnant. It is not known if Busulfex is found in breast milk. Do not breast-feed while taking Busulfex.


Possible side effects of Busulfex:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Anxiety; back pain; constipation; diarrhea; dizziness; dry mouth; flushing or hot flashes; headache; hiccup; indigestion; loss of appetite; mild fever or chills; mild redness or swelling at the injection site; minor cough or sore throat; muscle or joint pain; nausea; runny nose; tiredness or weakness; trouble sleeping; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); black, tarry stools; blurred vision or other vision changes; chest pain; confusion; decreased amount of urine, painful urination, or blood in the urine; depression; fainting; fast or irregular heartbeat; hallucinations; missed menstrual period; red, swollen, or blistered skin; seizures; severe or persistent pain, redness, or swelling at the injection site; severe or persistent cough; severe or persistent dizziness or headache; severe or persistent nausea, vomiting, or diarrhea; shortness of breath or trouble breathing; signs of infection (eg, persistent fever, chills, or sore throat); sores in the mouth or trouble swallowing; unusual bruising or bleeding (eg, nosebleed); unusual pain or swelling of the legs or calves; unusual stomach pain, swelling, or weight gain; vomit that looks like coffee grounds; yellowing of the skin or eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Busulfex side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Busulfex:

Store Busulfex as directed on the prescription label. Store away from heat and light. Do not store in the bathroom. Keep Busulfex, as well as needles and syringes, out of the reach of children and away from pets.


General information:


  • If you have any questions about Busulfex, please talk with your doctor, pharmacist, or other health care provider.

  • Busulfex is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Busulfex. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Busulfex resources


  • Busulfex Side Effects (in more detail)
  • Busulfex Use in Pregnancy & Breastfeeding
  • Busulfex Drug Interactions
  • Busulfex Support Group
  • 0 Reviews for Busulfex - Add your own review/rating


  • Busulfex Prescribing Information (FDA)

  • Busulfex Advanced Consumer (Micromedex) - Includes Dosage Information

  • Busulfex Concise Consumer Information (Cerner Multum)

  • Busulfan Professional Patient Advice (Wolters Kluwer)

  • Busulfan Monograph (AHFS DI)

  • Myleran Prescribing Information (FDA)



Compare Busulfex with other medications


  • Bone Marrow Transplantation
  • Chronic Myelogenous Leukemia
  • Thrombocythemia

Thursday, 23 December 2010

Atralin


Atralin is a brand name of tretinoin topical, approved by the FDA in the following formulation(s):


ATRALIN (tretinoin - gel; topical)



  • Manufacturer: DOW PHARM SCIENCES

    Approval date: July 26, 2007

    Strength(s): 0.05% [RLD]

Has a generic version of Atralin been approved?


No. There is currently no therapeutically equivalent version of Atralin available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Atralin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Moisturizing vehicle for topical application of vitamin A acid
    Patent 5,670,547
    Issued: September 23, 1997
    Inventor(s): Milstein; Elliott A. & Milstein; Nathan
    Assignee(s): Dow Pharmaceutical Sciences
    A formulation containing tretinoin, a gelling agent, proteinaceous material, and water is provided for the uniform topical application of tretinoin. The water-based formulation is oil- and fat-free, alcohol-free, and rich in proteinaceous material. The formulation is stable over time and is comedogenic and less irritating and drying to the skin.
    Patent expiration dates:

    • September 23, 2014
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • July 26, 2010 - NEW PRODUCT

See also...

  • Atralin Consumer Information (Drugs.com)
  • Atralin Consumer Information (Cerner Multum)
  • Atralin Topical Advanced Consumer Information (Micromedex)
  • Retin A Consumer Information (Drugs.com)
  • Tretinoin Cream Consumer Information (Wolters Kluwer)
  • Tretinoin Emollient Cream Consumer Information (Wolters Kluwer)
  • Tretinoin Gel Consumer Information (Wolters Kluwer)
  • Tretinoin Liquid Consumer Information (Wolters Kluwer)
  • Tretinoin topical Consumer Information (Cerner Multum)
  • Rejuva-A Topical Advanced Consumer Information (Micromedex)
  • Retin-A Micro Topical Advanced Consumer Information (Micromedex)
  • Vitamin A Acid Topical Advanced Consumer Information (Micromedex)
  • Tretinoin Topical Advanced Consumer Information (Micromedex)
  • Tretinoin topical AHFS DI Monographs (ASHP)

Wednesday, 22 December 2010

Toremifene




In the US, Toremifene (toremifene systemic) is a member of the following drug classes: hormones/antineoplastics, selective estrogen receptor modulators and is used to treat Breast Cancer and Breast Cancer - Metastatic.

US matches:

  • Toremifene

  • Toremifene Citrate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L02BA02

CAS registry number (Chemical Abstracts Service)

0089778-26-7

Chemical Formula

C26-H28-Cl-N-O

Molecular Weight

405

Therapeutic Categories

Antineoplastic agent

Antiestrogen

Chemical Name

2-[p-[(Z)-4-Chloro-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethylethylamine

Foreign Names

  • Toremifenum (Latin)
  • Toremifen (German)
  • Torémifène (French)
  • Toremifeno (Spanish)

Generic Names

  • Toremifene (OS: BAN)
  • Torémifène (OS: DCF)
  • FC 1157 (IS: FarmosGroupLt)
  • Toremifene Citrate (OS: USAN)
  • FC 1157a (IS: FarmosGroupLt)

Brand Names

  • Fareston
    Abdi Ibrahim, Turkey; Orion, United Arab Emirates; Orion, Bahrain; Orion, Czech Republic; Orion, Egypt; Orion, Ireland; Orion, Iraq; Orion, Iran; Orion, Jordan; Orion, Kuwait; Orion, Lebanon; Orion, Oman; Orion, Qatar; Orion, Saudi Arabia; Orion, Slovenia; Orion, Syria; Orion, Taiwan; Orion, Yemen; Baxter, Belgium; Baxter Oncology, Germany; GTx, United States; HRA, France; Nippon Kayaku, Japan; Orion, Austria; Orion, Switzerland; Orion, Finland; Orion, Finland; Orion, United Kingdom; Orion, Georgia; Orion, Hungary; Orion, Luxembourg; Orion, Russian Federation; Orion, Sweden; Schering-Plough, Australia; Schering-Plough, Bahrain; Schering-Plough, Spain; Schering-Plough, Italy; Schering-Plough, New Zealand; Schering-Plough, Portugal; Schering-Plough, Thailand; Schering-Plough, South Africa


  • Toremifene
    Medisa Shinyaku, Japan

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Fentanyl-Acino




Fentanyl-Acino may be available in the countries listed below.


Ingredient matches for Fentanyl-Acino



Fentanyl

Fentanyl is reported as an ingredient of Fentanyl-Acino in the following countries:


  • Germany

International Drug Name Search

Saturday, 18 December 2010

Xanaes




Xanaes may be available in the countries listed below.


Ingredient matches for Xanaes



Azelastine

Azelastine hydrochloride (a derivative of Azelastine) is reported as an ingredient of Xanaes in the following countries:


  • Argentina

International Drug Name Search

Sertralina Mundogen




Sertralina Mundogen may be available in the countries listed below.


Ingredient matches for Sertralina Mundogen



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralina Mundogen in the following countries:


  • Spain

International Drug Name Search

Dalmane




In the US, Dalmane (flurazepam systemic) is a member of the drug class benzodiazepines and is used to treat Insomnia.

US matches:

  • Dalmane

Ingredient matches for Dalmane



Flurazepam

Flurazepam monohydrochloride (a derivative of Flurazepam) is reported as an ingredient of Dalmane in the following countries:


  • Ireland

  • Malta

  • United States

International Drug Name Search

Wednesday, 15 December 2010

Epirubicine HCL Hikma




Epirubicine HCL Hikma may be available in the countries listed below.


Ingredient matches for Epirubicine HCL Hikma



Epirubicin

Epirubicin hydrochloride (a derivative of Epirubicin) is reported as an ingredient of Epirubicine HCL Hikma in the following countries:


  • Netherlands

International Drug Name Search

Friday, 10 December 2010

Risperdal M-Tab


Generic Name: risperidone (Oral route)

ris-PER-i-done

Oral route(Tablet;Tablet, Disintegrating;Solution)

Elderly patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo. Although the causes of death in clinical trials were varied, most of the deaths appeared to be either cardiovascular (eg, heart failure, sudden death) or infectious (eg, pneumonia) in nature. Observational studies suggest that antipsychotic drugs may increase mortality. It is unclear from the observational studies to what extent these mortality findings may be attributed to the antipsychotic drug as opposed to patient characteristics. Risperidone is not approved for the treatment of patients with dementia-related psychosis .



Commonly used brand name(s)

In the U.S.


  • Risperdal

  • Risperdal M-Tab

Available Dosage Forms:


  • Tablet, Disintegrating

  • Tablet

  • Solution

Therapeutic Class: Antipsychotic


Chemical Class: Benzisoxazole


Uses For Risperdal M-Tab


Risperidone is used to treat the symptoms of psychotic disorders, such as schizophrenia, mania or bipolar disorder, or irritability associated with autistic disorder. This medicine should NOT be used to treat behavioral problems in older adult patients who have dementia .


Risperidone is available only with your doctor's prescription.


Before Using Risperdal M-Tab


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of risperidone in children less than 13 years of age with schizophrenia. Safety and efficacy have not been established .


Appropriate studies have not been performed on the relationship of age to the effects of risperidone in children less than 10 years of age with bipolar disorder. Safety and efficacy have not been established .


Appropriate studies have not been performed on the relationship of age to the effects of risperidone in children less than 5 years of age with autistic disorder. Safety and efficacy have not been established .


Geriatric


Elderly people may be especially sensitive to the effects of risperidone. This may increase the chance of having side effects during treatment. This medicine should not be used for behavioral problems in older adults with dementia.


Appropriate studies performed to date have not demonstrated geriatrics-specific problems that would limit the usefulness of risperidone in the elderly. However, elderly patients are more likely to have age-related liver, kidney, or heart problems, which may require an adjustment of dosage in patients receiving risperidone .


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Bepridil

  • Cisapride

  • Levomethadyl

  • Mesoridazine

  • Metoclopramide

  • Pimozide

  • Terfenadine

  • Thioridazine

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Acecainide

  • Ajmaline

  • Amiodarone

  • Amisulpride

  • Amitriptyline

  • Amoxapine

  • Aprindine

  • Arsenic Trioxide

  • Asenapine

  • Astemizole

  • Azimilide

  • Bretylium

  • Chloral Hydrate

  • Chloroquine

  • Chlorpromazine

  • Citalopram

  • Clarithromycin

  • Desipramine

  • Dibenzepin

  • Disopyramide

  • Dofetilide

  • Dolasetron

  • Doxepin

  • Droperidol

  • Encainide

  • Enflurane

  • Erythromycin

  • Flecainide

  • Fluconazole

  • Foscarnet

  • Gemifloxacin

  • Ginkgo Biloba

  • Halofantrine

  • Haloperidol

  • Halothane

  • Hydromorphone

  • Hydroquinidine

  • Ibutilide

  • Imipramine

  • Isoflurane

  • Isradipine

  • Lidoflazine

  • Linezolid

  • Lithium

  • Lorcainide

  • Mefloquine

  • Milnacipran

  • Nortriptyline

  • Octreotide

  • Pentamidine

  • Pirmenol

  • Prajmaline

  • Probucol

  • Procainamide

  • Prochlorperazine

  • Propafenone

  • Protriptyline

  • Quetiapine

  • Sematilide

  • Sertindole

  • Simvastatin

  • Sotalol

  • Spiramycin

  • Sulfamethoxazole

  • Sultopride

  • Tedisamil

  • Telithromycin

  • Tetrabenazine

  • Tramadol

  • Trifluoperazine

  • Trimethoprim

  • Trimipramine

  • Vasopressin

  • Zolmitriptan

  • Zotepine

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Bupropion

  • Carbamazepine

  • Cimetidine

  • Fluoxetine

  • Itraconazole

  • Lamotrigine

  • Levorphanol

  • Methadone

  • Midodrine

  • Paroxetine

  • Phenobarbital

  • Phenytoin

  • Ranitidine

  • Ritonavir

  • Valproic Acid

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Aspiration pneumonia, risk or history of or

  • Blood circulation problems or

  • Dehydration or

  • Dementia, such as decreasing mental ability or

  • Difficulty swallowing—These conditions may increase the chance of serious side effects from the medicine .

  • Breast cancer or

  • Heart or blood vessel problems, including stroke and unusual heartbeats or

  • Parkinson's disease—Risperidone may make these conditions worse.

  • Diabetes or family history of diabetes—May make condition worse and cause serious side effects.

  • Drug abuse problems in the past—These patients should be observed for any signs of abuse of this medicine.

  • Epilepsy or other seizure disorders—Risperidone may increase the risk of having seizures.

  • Kidney disease or

  • Liver disease—Higher blood levels of risperidone may occur, increasing the chance of side effects.

  • Other medical problems causing vomiting (e.g., brain tumor, bowel blockage, drug overdose, Reye's syndrome)—Risperidone may prevent vomiting and hide these medical problems from you and your doctor.

  • Phenylketonuria (PKU)—The oral disintegrating tablets may contain aspartame, which can make your condition worse.

Proper Use of risperidone

This section provides information on the proper use of a number of products that contain risperidone. It may not be specific to Risperdal M-Tab. Please read with care.


Take this medicine only as directed by your doctor to benefit your condition as much as possible. Do not take more or less of it, do not take it more or less often, and do not take it for a longer or shorter time than your doctor ordered.


You may take this medicine with or without food .


For patients taking the oral solution form of risperidone:


  • Measure the dose with the measuring device provided with your medicine. Stir the dose into a small glass (3 to 4 ounces) of water, coffee, orange juice, or low-fat milk just before taking it. Do not mix this medicine with cola or tea.

  • Rinse the empty measuring device with water and place it back in its storage case. Put the plastic cap back on the bottle of medicine.

For patients taking the orally disintegrating tablet form of risperidone:


  • Do not open the package until you are ready to take your medicine. To remove one tablet, separate one of the four tablets by tearing apart on perforations. Bend the corner as shown on the package. Peel back the foil to get to the tablet. Do not push the tablet through the foil because that could damage the tablet.

  • Use dry hands and take the tablet out of the package and immediately place it on your tongue. The tablet needs to be used immediately because it cannot be stored once it is taken out of the package. Once the tablet is on your tongue it will disintegrate in seconds. You can swallow it with or without liquid. It is important not to split or chew the tablet.

Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (oral solution, tablets, or orally disintegrating tablets):
    • For bipolar mania:
      • Adults—At first, 2 to 3 milligrams (mg) per day, given on a once a day schedule. Your doctor may increase your dose as needed. However, the dose usually is not more than 6 mg a day.

      • Children 10 to 17 years of age—At first, 0.5 milligrams (mg) per day, given on a once a day schedule either in the morning or evening. Your doctor may increase your dose as needed. However, the dose usually is not more than 6 mg a day.

      • Children younger than 10 years of age—Use and dose must be determined by your doctor.

      • Older adults—At first, 0.25 mg or 0.5 mg (0.5 mL) two times a day. The medicine can be given on a once a day schedule after your doctor has found the correct dose for you. Your doctor may increase your dose as needed. However, the dose usually is not more than 3 mg (3 mL) a day .


    • For irritability associated with autistic disorder:
      • Children 5 to 16 years of age weighing 20 kilograms (kg) or greater—At first, 0.5 milligrams (mg) per day, given on a once a day or twice a day schedule. Your doctor may increase your dose as needed.

      • Children 5 to 16 years of age weighing less than 20 kilograms (kg)—At first, 0.25 milligrams (mg) per day, given on a once a day or twice a day schedule. Your doctor may increase your dose as needed.

      • Children younger than 5 years of age—Use and dose must be determined by your doctor .


    • For schizophrenia:
      • Adults—At first, 2 milligrams (mg) per day, given on a once a day or twice a day schedule. Your doctor may increase your dose as needed. However, the dose usually is not more than 16 mg a day.

      • Children 13 to 17 years of age—At first, 0.5 milligrams (mg) per day, given on a once a day schedule either in the morning or evening. Your doctor may increase your dose as needed. However, the dose usually is not more than 6 mg a day.

      • Children younger than 13 years of age—Use and dose must be determined by your doctor.

      • Older adults—At first, 0.25 mg or 0.5 mg (0.5 mL) two times a day. The medicine can be given on a once a day schedule after your doctor has found the correct dose for you. Your doctor may increase your dose as needed. However, the dose usually is not more than 3 mg (3 mL) a day .



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using Risperdal M-Tab


Your doctor should check your progress at regular visits, especially during the first few months of treatment with this medicine. This will allow the dosage to be changed if necessary to meet your needs.


Do not stop taking this medicine without first checking with your doctor. Your doctor may want you to reduce gradually the amount you are taking before stopping completely. This is to prevent side effects and to keep your condition from becoming worse.


This medicine may add to the effects of alcohol and other CNS depressants (medicine that makes you drowsy or less alert). Some examples of CNS depressants are antihistamines or medicine for hay fever, other allergies, or colds; sedatives, tranquilizers, or sleeping medicine; prescription pain medicine or narcotics; barbiturates; medicine for seizures; muscle relaxants; or anesthetics, including some dental anesthetics. Check with your doctor before taking any of the above while you are using this medicine.


Before having any kind of surgery, dental treatment, or emergency treatment, tell the medical doctor or dentist in charge that you are using this medicine. Taking risperidone together with medicines that are used during surgery, dental, or emergency treatments may increase the CNS depressant effects.


This medicine may cause blurred vision, dizziness, or drowsiness. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are not alert or able to see clearly.


Dizziness, lightheadedness, or fainting may occur, especially when you get up from a lying or sitting position. Getting up slowly may help. If the problem continues or gets worse, check with your doctor.


Risperidone may cause your skin to be more sensitive to sunlight than it is normally. Exposure to sunlight, even for brief periods of time, may cause a skin rash, itching, redness or other discoloration of the skin, or a severe sunburn. When you begin taking this medicine:


  • Stay out of direct sunlight, especially between the hours of 10:00 a.m. and 3:00 p.m., if possible.

  • Wear protective clothing, including a hat. Also, wear sunglasses.

  • Apply a sun block product that has a skin protection factor (SPF) of at least 15. You may require a product with a higher SPF number, especially if you have a fair complexion. If you have any questions about this, check with your health care professional.

  • Apply a sun block lipstick that has an SPF of at least 15 to protect your lips.

  • Do not use a sunlamp or tanning bed or booth.

If you have a severe reaction from the sun, check with your doctor.


This medicine may make it more difficult for your body to keep a constant temperature. Use extra care not to become overheated during exercise or hot weather while you are taking this medicine, since overheating may result in heatstroke. Hot baths or saunas may make you feel dizzy or faint while you are taking this medicine. Also, use extra care not to become too cold while you are taking risperidone. If you become too cold, you may feel drowsy, confused, or clumsy.


Risperdal M-Tab Side Effects


Along with its needed effects, risperidone can sometimes cause serious side effects. Tardive dyskinesia (a movement disorder) may occur and may not go away after you stop using the medicine. Signs of tardive dyskinesia include fine, worm-like movements of the tongue, or other uncontrolled movements of the mouth, tongue, cheeks, jaw, or arms and legs. Other serious but rare side effects may also occur. These include neuroleptic malignant syndrome (NMS), which may cause severe muscle stiffness, fever, severe tiredness or weakness, fast heartbeat, difficult breathing, increased sweating, loss of bladder control, or seizures. You and your doctor should discuss the good this medicine will do as well as the risks of taking it.


Stop taking this medicine and get emergency help immediately if any of the following effects occur:


Rare
  • Convulsions (seizures)

  • difficult or fast breathing

  • fast heartbeat or irregular pulse

  • fever (high)

  • high or low blood pressure

  • increased sweating

  • loss of bladder control

  • muscle stiffness (severe)

  • unusual tiredness or weakness (severe)

  • unusually pale skin

Check with your doctor immediately if any of the following side effects occur:


More common
  • Difficulty in speaking or swallowing

  • inability to move eyes

  • muscle spasms of face, neck, and back

  • twisting movements of body

Less common
  • Speech or vision problems

  • sudden weakness or numbness in the face, arms or legs

Rare
  • High body temperature (dizziness; fast, shallow breathing; fast, weak heartbeat; headache; muscle cramps; pale, clammy skin; increased thirst)

  • lip smacking or puckering

  • low body temperature (confusion, drowsiness, poor coordination, shivering)

  • prolonged, painful, inappropriate erection of the penis

  • puffing of cheeks

  • rapid or worm-like movements of tongue

  • uncontrolled chewing movements

  • uncontrolled movements of arms and legs

Check with your doctor as soon as possible if any of the following side effects occur:


More common
  • Anxiety or nervousness

  • changes in vision, including blurred vision

  • decreased sexual desire or performance

  • loss of balance control

  • mask-like face

  • menstrual changes

  • mood or mental changes, including aggressive behavior, agitation, difficulty in concentration, and memory problems

  • problems in urination or increase in amount of urine

  • restlessness or need to keep moving (severe)

  • shuffling walk

  • skin rash or itching

  • stiffness or weakness of arms or legs

  • tic-like or twitching movements

  • trembling and shaking of fingers and hands

  • trouble in sleeping

Less common
  • Back pain

  • chest pain

  • unusual secretion of milk

Rare
  • Extreme thirst

  • increased blinking or spasms of eyelid

  • loss of appetite

  • talking, feeling, and acting with excitement and activity that cannot be controlled

  • uncontrolled twisting movements of neck, trunk, arms, or legs

  • unusual bleeding or bruising

  • unusual facial expressions or body positions

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Constipation

  • coughing

  • diarrhea

  • drowsiness

  • dryness of mouth

  • headache

  • heartburn

  • increased dream activity

  • increased length of sleep

  • nausea

  • sleepiness or unusual drowsiness

  • sore throat

  • stuffy or runny nose

  • unusual tiredness or weakness

  • weight gain

Less common
  • Back pain

  • body aches or pain

  • chills

  • dandruff

  • darkening of skin color

  • dry skin

  • ear congestion

  • fever

  • increase in body movements

  • increased sensitivity of the skin to sun

  • increased watering of mouth

  • joint pain

  • loss of voice

  • nasal congestion

  • oily skin

  • pain or tenderness around eyes and cheekbones

  • shortness of breath or troubled breathing

  • sneezing

  • stomach pain

  • tightness of chest or wheezing

  • toothache

  • vomiting

  • weight loss

Some side effects, such as uncontrolled movements of the mouth, tongue, and jaw, or uncontrolled movements of arms and legs, may occur after you have stopped taking this medicine. If you notice any of these effects, check with your doctor as soon as possible.


Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Risperdal M-Tab side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Risperdal M-Tab resources


  • Risperdal M-Tab Side Effects (in more detail)
  • Risperdal M-Tab Use in Pregnancy & Breastfeeding
  • Drug Images
  • Risperdal M-Tab Drug Interactions
  • Risperdal M-Tab Support Group
  • 3 Reviews for Risperdal M-Tab - Add your own review/rating


  • Risperdal M-Tab Orally Disintegrating Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Risperdal Prescribing Information (FDA)

  • Risperdal Consumer Overview

  • Risperdal Monograph (AHFS DI)

  • Risperdal MedFacts Consumer Leaflet (Wolters Kluwer)

  • Risperdal Consta Prescribing Information (FDA)

  • Risperdal Consta MedFacts Consumer Leaflet (Wolters Kluwer)

  • Risperdal Consta Consumer Overview

  • Risperidone Prescribing Information (FDA)

  • Risperidone Professional Patient Advice (Wolters Kluwer)



Compare Risperdal M-Tab with other medications


  • Asperger Syndrome
  • Autism
  • Bipolar Disorder
  • Schizoaffective Disorder
  • Schizophrenia

Monday, 6 December 2010

Sesaren




Sesaren may be available in the countries listed below.


Ingredient matches for Sesaren



Venlafaxine

Venlafaxine is reported as an ingredient of Sesaren in the following countries:


  • Chile

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Sesaren in the following countries:


  • Argentina

  • Venezuela

International Drug Name Search

Friday, 3 December 2010

Oribact




Oribact may be available in the countries listed below.


Ingredient matches for Oribact



Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Oribact in the following countries:


  • Bahrain

  • United Arab Emirates

Trimethoprim

Trimethoprim is reported as an ingredient of Oribact in the following countries:


  • Bahrain

  • United Arab Emirates

International Drug Name Search

Friday, 26 November 2010

Infectocortikrupp




Infectocortikrupp may be available in the countries listed below.


Ingredient matches for Infectocortikrupp



Prednisolone

Prednisolone 21-acetate (a derivative of Prednisolone) is reported as an ingredient of Infectocortikrupp in the following countries:


  • Germany

International Drug Name Search

Lobevat




Lobevat may be available in the countries listed below.


Ingredient matches for Lobevat



Clobetasol

Clobetasol 17α-propionate (a derivative of Clobetasol) is reported as an ingredient of Lobevat in the following countries:


  • Chile

  • Colombia

  • Mexico

  • Peru

  • Venezuela

International Drug Name Search

Monday, 22 November 2010

Foscarnet Sodium Injection




Ingredient matches for Foscarnet Sodium Injection



Foscarnet

Foscarnet Sodium is reported as an ingredient of Foscarnet Sodium Injection in the following countries:


  • United States

International Drug Name Search

Wednesday, 17 November 2010

Atenomel




Atenomel may be available in the countries listed below.


Ingredient matches for Atenomel



Atenolol

Atenolol is reported as an ingredient of Atenomel in the following countries:


  • Ireland

International Drug Name Search

Thursday, 4 November 2010

Carbamazepin-biomo




Carbamazepin-biomo may be available in the countries listed below.


Ingredient matches for Carbamazepin-biomo



Carbamazepine

Carbamazepine is reported as an ingredient of Carbamazepin-biomo in the following countries:


  • Germany

International Drug Name Search

Wednesday, 3 November 2010

Atenolol Gador




Atenolol Gador may be available in the countries listed below.


Ingredient matches for Atenolol Gador



Atenolol

Atenolol is reported as an ingredient of Atenolol Gador in the following countries:


  • Argentina

International Drug Name Search

Saturday, 23 October 2010

Ribasphere Ribapak


Generic Name: ribavirin (Oral route)

rye-ba-VYE-rin

Oral route(Tablet;Capsule;Solution)

Ribavirin is not effective for monotherapy treatment of chronic hepatitis C virus infection. The primary toxicity is hemolytic anemia which may result in worsening of cardiac disease and fatal and nonfatal myocardial infarctions. Avoid use in patients with significant or unstable cardiac disease. Significant teratogenic and/or embryocidal effects have been demonstrated in all animal species exposed to ribavirin. Ribavirin is contraindicated in women who are pregnant and in male partners of women who are pregnant. Use 2 reliable forms of contraception and avoid pregnancy during therapy and for 6 months after completion of treatment in both female patients and in female partners of male patients who are taking ribavirin .



Commonly used brand name(s)

In the U.S.


  • Copegus

  • Rebetol

  • RibaPak

  • Ribasphere

  • Ribasphere Ribapak

  • RibaTab

Available Dosage Forms:


  • Tablet

  • Solution

  • Capsule

Therapeutic Class: Antiviral


Pharmacologic Class: Viral RNA Polymerase Inhibitor


Chemical Class: Guanosine Nucleoside Analog


Uses For Ribasphere Ribapak


Ribavirin is used in combination with injectable interferon alfa-2b, peginterferon alfa-2a, or peginterferon alfa-2b to treat chronic hepatitis C infection. The combination of ribavirin and peginterferon alfa-2b is used to treat adults and children 3 years of age and older who show symptoms of liver damage. Ribavirin is an antiviral agent that treats hepatitis C virus.


This medicine is available only with your doctor's prescription.


Before Using Ribasphere Ribapak


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of ribavirin tablets in children younger than 5 years of age, ribavirin capsules and oral liquid in children younger than 3 years of age. The safety and efficacy of ribavirin tablets, capsules, and oral liquid have not been established in these age groups.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of ribavirin in the elderly. However, elderly patients are more likely to have age-related liver, kidney, or heart problems, which may require an adjustment in the dose for patients receiving ribavirin.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersXStudies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities. This drug should not be used in women who are or may become pregnant because the risk clearly outweighs any possible benefit.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Didanosine

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Abacavir

  • Azathioprine

  • Lamivudine

  • Stavudine

  • Zalcitabine

  • Zidovudine

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Interferon Alfa-2b

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Autoimmune hepatitis (liver inflammation) or

  • Heart disease (unstable), or history of or

  • Liver disease (including cirrhosis), severe or

  • Sickle cell anemia (red blood cell disorder) or

  • Thalassemia major (genetic blood disorder)—Should not be used in patients with these conditions.

  • Blood or bone marrow problems (e.g., anemia, pancytopenia) or

  • Breathing problems and lung disease (e.g., pneumonia, pulmonary infiltrates, pulmonary hypertension) or

  • Colitis (inflammation of the colon) or

  • Depression or

  • Diabetes or

  • Drug abuse, history of or

  • Eye or vision problems (e.g., loss of vision, retinopathy) or

  • Heart attack, history of or

  • Heart or blood vessel disease, history of or

  • Hypertension (high blood pressure) or

  • Pancreatitis (inflammation of the pancreas) or

  • Sarcoidosis (lung disease) or

  • Thyroid disease or

  • Weakened immune system—Use with caution. May make these conditions worse.

  • Blood problems (e.g., spherocytosis) or

  • Stomach problems (e.g., bleeding), history of—Use with caution. May increase risk for severe anemia.

  • Infection (e.g., adenovirus, RSV) or

  • Influenza or parainfluenza—Copegus® should not be used in patients with these conditions. Your doctor may give you inhaled ribavirin.

  • Kidney disease—Higher blood levels of ribavirin can occur, which increases the risk of serious side effects.

  • Liver disease, decompensated or

  • Organ transplant (e.g., liver, kidney)—Use of ribavirin and peginterferon alfa-2a combination have not been established in patients with these conditions.

Proper Use of ribavirin

This section provides information on the proper use of a number of products that contain ribavirin. It may not be specific to Ribasphere Ribapak. Please read with care.


To help clear up your infection completely, ribavirin must be given for the full time of treatment, even if you or your child begins to feel better after a few days. Also, it is important to keep the amount of medicine in your body at a steady level. To help keep the amount constant, ribavirin must be given on a regular schedule.


You should take this medicine with food.


Swallow the capsule whole. Do not crush, break, or open it.


Measure the oral liquid with a marked measuring cup or spoon. Wash the cup or spoon after each use.


This medicine should come with a Medication Guide. Read and follow the information carefully. Ask your doctor if you have any questions. Ask your pharmacist for the Medication Guide if you do not have one.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For hepatitis C virus infection, in combination with interferon alfa-2b:
    • For oral dosage form (capsules):
      • Adults—Dose is based on body weight and must be determined by your doctor. The dose is usually 1000 to 1200 milligrams (mg) per day, given as two or three capsules in the morning and three capsules at night.

      • Children 3 years of age and older—Dose is based on body weight and must be determined by your doctor. The dose is usually 15 milligrams (mg) per kilogram (kg) of body weight per day, given in 2 divided doses and taken in the morning and evening.

      • Children younger than 3 years of age—Use and dose must be determined by your doctor.


    • For oral dosage form (solution):
      • Adults—Dose is based on body weight and must be determined by your doctor. The oral solution form of this medicine is not usually prescribed for adults and teenagers.

      • Children 3 years of age and older—Dose is based on body weight and must be determined by your doctor. The dose is usually 15 milligrams (mg) per kilogram (kg) of body weight per day, given in 2 divided doses and taken in the morning and evening.

      • Children younger than 3 years of age—Use and dose must be determined by your doctor.



  • For hepatitis C virus infection, in combination with peginterferon alfa-2b:
    • For oral dosage form (capsules):
      • Adults—Dose is based on body weight and must be determined by your doctor. The dose is usually 800 to 1400 milligrams (mg) per day, given as two to three capsules in the morning and two to four capsules at night.

      • Children 3 years of age and older—Dose is based on body weight and must be determined by your doctor. The dose is usually 15 milligrams (mg) per kilogram (kg) of body weight per day, given in 2 divided doses and taken in the morning and evening.

      • Children younger than 3 years of age—Use and dose must be determined by your doctor.


    • For oral dosage form (solution):
      • Adults—Dose is based on body weight and must be determined by your doctor. The oral solution form of this medicine is not usually prescribed for adults and teenagers.

      • Children 3 years of age and older—Dose is based on body weight and must be determined by your doctor. The dose is usually 15 milligrams (mg) per kilogram (kg) of body weight per day, given in two divided doses and taken in the morning and evening.

      • Children younger than 3 years of age—Use and dose must be determined by your doctor.



  • For hepatitis C virus infection, in combination with peginterferon alfa-2a:
    • For oral dosage form (tablets):
      • Adults—Dose is based on body weight and must be determined by your doctor. The dose is usually 800 to 1200 milligrams (mg) per day, given in 2 divided doses and taken in the morning and evening.

      • Children 5 years of age and older—Dose is based on body weight and must be determined by your doctor. The dose is usually 400 to 1200 mg per day, given in 2 divided doses and taken in the morning and evening.

      • Children younger than 5 years of age—Use and dose must be determined by your doctor.



  • For hepatitis C with HIV virus coinfection, in combination with peginterferon alfa-2a:
    • For oral dosage form (tablets):
      • Adults—800 milligrams (mg) per day.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Store the capsules and tablets in a closed container at room temperature, away from heat, moisture, and direct light.


Store the oral liquid in the refrigerator or at room temperature, away from heat and direct light. Do not freeze.


Precautions While Using Ribasphere Ribapak


It is very important that your doctor check the progress of you or your child at regular visits to make sure this medicine is working properly. Blood tests may be needed to check for unwanted effects.


Using this medicine while you are pregnant can harm your unborn baby. The medicine may also cause birth defects if the father is using it when his sexual partner becomes pregnant. If a pregnancy occurs while you are using this medicine, tell your doctor right away.


It is important to tell your doctor if you or your female sexual partner become pregnant. Your doctor may want you to join a pregnancy registry for patients taking this medicine.


A negative pregnancy test is needed in women who are of childbearing age before starting treatment with this medicine. Two forms of birth control must be used together during treatment and for 6 months after treatment ends. You will need to have pregnancy tests done regularly to make sure you are not pregnant while being treated with this medicine and after your treatment ends.


Do not use Copegus® in combination with didanosine (Videx®, Videx® EC). Using these medicines together may cause serious medical problems.


Ribavirin may cause some people to be agitated, irritable, or display other abnormal behaviors. It may also cause some people to have suicidal thoughts and tendencies or to become more depressed. If you, your child, or your caregiver notice any of these side effects, tell your doctor or your child's doctor right away.


Check with your doctor right away if you or your child have back, leg, or stomach pains; bleeding gums; chills; dark urine; difficulty breathing; fever; general body swelling; headache; loss of appetite; nausea or vomiting; nosebleeds; pale skin; sore throat; unusual tiredness or weakness; or yellowing of the eyes or skin. These could be symptoms of a blood disorder called anemia.


This medicine may cause serious types of allergic reactions, including anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Stop taking this medicine and call your doctor right away if you or your child have itching, hives, hoarseness, trouble with breathing, trouble with swallowing, or any swelling of the hands, face, or mouth while you are using this medicine.


Serious skin reactions can occur with this medicine. Check with your doctor right away if you or your child have blistering, peeling, or loosening of the skin; fever or chills; hives or welts; red skin lesions; a severe skin rash or acne; or sores or ulcers on the skin while you are using this medicine.


Pancreatitis may occur while you are using this medicine. Stop using this medicine and check with your doctor right away if you or your child have sudden and severe stomach pain, chills, constipation, nausea, vomiting, fever, or lightheadedness.


You or your teenager should not drink alcoholic beverages (including beer, wine, or liquor) while you are taking this medicine.


This medicine may cause some people to become dizzy, drowsy, or less alert than they are normally. Make sure you know how you react to this medicine before you or your teenager drive, operate machinery, or do anything else that could be dangerous if you are not alert.


Check with your doctor if blurred vision, decreased vision, or any other change in vision occurs while you or your child are using this medicine. Your doctor may want you to have your eyes checked by an ophthalmologist (eye doctor).


Peginterferon injection combined with ribavirin can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets in the blood, which are necessary for proper blood clotting. If this occurs, there are certain precautions you or your child can take, especially when your blood count is low, to reduce the risk of infection or bleeding:


  • If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.

  • Check with your doctor immediately if you notice any unusual bleeding or bruising; black, tarry stools; blood in the urine or stools; or pinpoint red spots on your skin.

  • Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.

  • Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.

  • Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.

  • Avoid contact sports or other situations where bruising or injury could occur.

This medicine may cause teeth and gum problems. This medicine may cause dryness of the mouth, and a dry mouth may damage your teeth and gums if you take the medicine for a long time. To help prevent this condition, carefully brush your teeth at least two times a day and have regular visits with your dentist. For temporary relief of mouth dryness, use sugarless candy or gum, melt bits of ice in your mouth, or use a saliva substitute.


Some patients who have used this medicine have had vomiting. If you vomit during your treatment, rinse your mouth out with water. This may also help prevent damage to your teeth and gums.


Ribavirin used together with injectable peginterferon alfa-2a or peginterferon alfa-2b may affect your child's growth. Your doctor may need to check your child's height and weight during and after treatment with these medicines.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.


Ribasphere Ribapak Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Anxiety

  • black, tarry stools

  • body aches or pain

  • chest pain

  • congestion

  • cough or hoarseness

  • crying

  • depersonalization

  • diarrhea

  • difficult or labored breathing

  • discouragement

  • dry mouth

  • dryness of the throat

  • dysphoria

  • euphoria

  • feeling sad or empty

  • feeling unusually cold

  • fever or chills

  • general feeling of discomfort or illness

  • headache

  • hyperventilation

  • irregular heartbeats

  • irritability

  • joint pain

  • lack of appetite

  • loss of interest or pleasure

  • lower back or side pain

  • mental depression

  • muscle aches and pains

  • nausea

  • nervousness

  • painful or difficult urination

  • pale skin

  • paranoia

  • poor concentration

  • quick to react or overreact emotionally

  • rapidly changing moods

  • restlessness

  • right upper abdominal or stomach pain

  • runny nose

  • shaking

  • shivering

  • shortness of breath

  • sleeplessness

  • sore throat

  • sores, ulcers, or white spots on the lips or in the mouth

  • sweating

  • tender, swollen glands in the neck

  • tightness in the chest

  • trouble with concentrating

  • trouble with sleeping

  • trouble with swallowing

  • troubled breathing with exertion

  • unable to sleep

  • unusual bleeding or bruising

  • unusual tiredness or weakness

  • voice changes

  • vomiting

  • wheezing

Less common
  • Bleeding gums

  • blood in the urine or stools

  • constipation

  • depressed mood

  • dry skin and hair

  • feeling cold

  • hair loss

  • husky voice

  • muscle cramps and stiffness

  • pinpoint red spots on the skin

  • right upper abdominal or stomach fullness

  • slowed heartbeat

  • weight gain

Incidence not known
  • Blistering, flaking, or peeling of the skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Acid or sour stomach

  • being forgetful

  • belching

  • blurred vision

  • bone pain

  • change in taste or bad, unusual, or unpleasant (after) taste

  • cracked, scaly skin

  • crusting, irritation, itching, or reddening of the skin

  • difficulty with moving

  • dizziness or lightheadedness

  • feeling of constant movement of self or surroundings

  • hair loss or thinning of the hair

  • heartburn

  • indigestion

  • lack or loss of strength

  • menstrual changes

  • pain or tenderness around the eyes and cheekbones

  • rash

  • sensation of spinning

  • sneezing

  • stomach discomfort, upset, or pain

  • stuffy nose

  • swelling

  • swollen joints

  • weight loss

Less common
  • Back pain

  • burning, dry, or itching eyes

  • discharge, excessive tearing

  • feeling of warmth

  • redness of the face, neck, arms, and occasionally, upper chest

  • redness, pain, swelling of the eye, eyelid, or inner lining of the eyelid

  • skin rash, encrusted, scaly, and oozing

Incidence not known
  • Change in hearing

  • loss of hearing

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Ribasphere Ribapak side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Ribasphere Ribapak resources


  • Ribasphere Ribapak Side Effects (in more detail)
  • Ribasphere Ribapak Use in Pregnancy & Breastfeeding
  • Drug Images
  • Ribasphere Ribapak Drug Interactions
  • Ribasphere Ribapak Support Group
  • 1 Review for Ribasphere Ribapak - Add your own review/rating


Compare Ribasphere Ribapak with other medications


  • Hepatitis C
  • Respiratory Syncytial Virus

Pyronal




Pyronal may be available in the countries listed below.


Ingredient matches for Pyronal



Metamizole

Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Pyronal in the following countries:


  • Indonesia

International Drug Name Search

Friday, 22 October 2010

Hidantin




Hidantin may be available in the countries listed below.


Ingredient matches for Hidantin



Phenytoin

Phenytoin sodium salt (a derivative of Phenytoin) is reported as an ingredient of Hidantin in the following countries:


  • Turkey

International Drug Name Search

Uplores




Uplores may be available in the countries listed below.


Ingredient matches for Uplores



Roxithromycin

Roxithromycin is reported as an ingredient of Uplores in the following countries:


  • Indonesia

International Drug Name Search

Thursday, 14 October 2010

Benzarone




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0001477-19-6

Chemical Formula

C17-H14-O3

Molecular Weight

266

Therapeutic Categories

Agent for antivaricose therapy

Vasoprotective agent

Chemical Name

Methanone, (2-ethyl-3-benzofuranyl)(4-hydroxyphenyl)-

Foreign Names

  • Benzaronum (Latin)
  • Benzaron (German)
  • Benzarone (French)
  • Benzarona (Spanish)

Generic Names

  • Benzarone (OS: DCF)
  • L 2197 (IS)

Brand Names

  • Fragivix
    Shyh Dar, Taiwan


  • Hemobend
    Hua Shin, Taiwan

International Drug Name Search

Glossary

DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 5 October 2010

Cerestab




Cerestab may be available in the countries listed below.


Ingredient matches for Cerestab



Exametazime

Exametazime is reported as an ingredient of Cerestab in the following countries:


  • France

International Drug Name Search

Saturday, 2 October 2010

Daktanol




Daktanol may be available in the countries listed below.


Ingredient matches for Daktanol



Miconazole

Miconazole is reported as an ingredient of Daktanol in the following countries:


  • Bosnia & Herzegowina

  • Serbia

International Drug Name Search

Friday, 1 October 2010

Visumidriatic




Visumidriatic may be available in the countries listed below.


Ingredient matches for Visumidriatic



Tropicamide

Tropicamide is reported as an ingredient of Visumidriatic in the following countries:


  • Italy

International Drug Name Search

Oxypor




Oxypor may be available in the countries listed below.


Ingredient matches for Oxypor



Benzoyl Peroxide

Benzoyl Peroxide is reported as an ingredient of Oxypor in the following countries:


  • Colombia

International Drug Name Search